| By the end of this activity, the participant should be better able to: |
| |
Compare the effectiveness of various therapeutic options as neuroprotective agents for early treatment of PD |
| |
Analyze the clinical study characteristics that make it difficult to conclusively demonstrate that a given therapeutic agent provides neuroprotection in PD |
| |
Identify nonmotor signs of PD and describe the evidence on the duration of the premotor phase of PD |
| |
Review the latest evidence on the use of clinical symptoms, imaging, and biomarkers to make an accurate early diagnosis of PD |